Effect of Medium Age and Supplementation with the Biocatalytic Oxygen-Reducing Reagent Oxyrase on In Vitro Activities of Tigecycline against Recent Clinical Isolates
Open Access
- 1 September 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (9), 3910-8
- https://doi.org/10.1128/aac.49.9.3910-3918.2005
Abstract
In determining the quality control limits for the Clinical Laboratory Standards Institute-recommended quality control organisms with tigecycline, a number of inconsistencies in the results were encountered that appeared to be related to the age of the Mueller-Hinton broth II. This study was performed to examine the effect of medium age and supplementation with Oxyrase on the activity of tigecycline using a large number of clinical isolates.Keywords
This publication has 11 references indexed in Scilit:
- Tigecycline MIC Testing by Broth Dilution Requires Use of Fresh Medium or Addition of the Biocatalytic Oxygen-Reducing Reagent Oxyrase To Standardize the Test MethodAntimicrobial Agents and Chemotherapy, 2005
- Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal EndocarditisAntimicrobial Agents and Chemotherapy, 2003
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental EndocarditisAntimicrobial Agents and Chemotherapy, 2000
- Preclinical Pharmacology of GAR-936, a Novel Glycylcycline Antibacterial AgentPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000
- Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936Bioorganic & Medicinal Chemistry Letters, 1999
- Effects of environmental factors on the in vitro potency of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991